Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering novel medicines for rare diseases in the United States and internationally. The company’s ...

In trading on Tuesday, shares of Amicus Therapeutics Inc (Symbol: FOLD) entered into oversold territory, hitting an RSI reading of 29.5, after changing hands as low as $6.35 per share. By ...